Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The Lancet HIV .PMID 31611038Read source Stanley TL, Falutz J, Mamputu JC, et al
The service will offer GLP-1 medication for those who qualify after receiving a prescription from one of its licensed medical providers
Similar content being viewed by others Subjects Main Dual agonism of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors (GLP-1R and GIPR, respectively), in the form of once-weekly injectable tirzepatide, is highly effective for treating people living with obesity and type 2 diabetes, resulting in greater weight loss than GLP-1R agonism alone 2
doi:10.1002/oby.24027 41
In a letter (PDF) to shareholders, executives said the company has a legal pathway to sell "personalized titration schedules and dosage levels that are not essentially copies of commercially available medications" that allow providers to "meet the needs of individual patients regardless of shortage dynamics." Hims & Hers said revenue from its non-GLP-1 offerings totaled $1.2 billion of the $1.48 billion that it brought in last year, suggesting the company sold roughly $200 million in compounded GLP-1 drugs last year
